Evidence map›Paper›PMID 37806772›Full record

ArticleJNCI cancer spectrum2023

An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals.

K Robin Yabroff, Amanda L Boehm, Leticia M Nogueira, Mark Sherman, Cathy J Bradley, Ya-Chen Tina Shih, Nancy L Keating, Scarlett L Gomez, Matthew P Banegas, Stefan Ambs and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JNCI cancer spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

K Robin YabroffSurveillance and Health Equity Science Department, American Cancer Society, Atlanta, GA, USA.ORCID 0000-0003-0644-5572
Amanda L BoehmOxford University Press, New York, NY, USA.
Leticia M NogueiraSurveillance and Health Equity Science Department, American Cancer Society, Atlanta, GA, USA.
Mark ShermanQuantitative Health Sciences, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA.
Cathy J BradleyUniversity of Colorado Comprehensive Cancer Center and Colorado School of Public Health, Aurora, CO, USA.ORCID 0000-0001-9429-6567
Ya-Chen Tina ShihUniversity of California Los Angeles Jonsson Comprehensive Cancer Center and Department of Radiation Oncology, School of Medicine, Los Angeles, CA, USA.
Nancy L KeatingDepartment of Health Care Policy, Harvard Medical School, and Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Scarlett L GomezDepartment of Urology and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Matthew P BanegasDepartment of Radiation Medicine and Applied Sciences, University of California at San Diego, San Diego, CA, USA.
Stefan AmbsLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0001-7651-9309
Dawn L HershmanDivision of Hematology/Oncology, Columbia University, New York, NY, USA.ORCID 0000-0001-8807-153X
James B YuDepartment of Radiation Oncology, St. Francis Hospital and Trinity Health of New England, Hartford, CT, USA.
Nadeem RiazDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-9873-5862
Martin R StocklerNational Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wells, Australia.
Ronald C ChenDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
Eduardo L FrancoDivision of Cancer Epidemiology, McGill University, Montreal, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsPeriodicals as TopicDiversity, Equity, InclusionGoalsHumansNational Cancer Institute (U.S.)United States

Identifiers

PMID37806772
PMCPMC10560610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.